Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1052203

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the barriers that may prevent England reaching zero HIV transmissions by 2030.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	215129
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>An expert group is to be established to develop an ‘Ending HIV transmission in England Action Plan’ by the autumn of 2019 that will set out the key policies and activities to achieve the goal of ending HIV transmission in England by 2030. An important aspect of this will be identifying the barriers to individualised risk assessment and prevention advice, testing and early treatment, focusing on high-risk groups, particularly gay and bisexual men, people who inject drugs and black and minority ethnic group populations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:42:45 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1051289

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will support the call by Kidney Cancer UK to fund research on a national screening programme for kidney cancer.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	214526
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.</p><p> </p><p>The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer, however, the Committee welcomes new topic proposals via its annual call for topics which opens each year from September - December.</p><p> </p><p>Ministers carefully consider all recommendations made by the UK NSC.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:47:54 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050632

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to reduce the number of incidences of misdiagnosis of kidney cancer.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213989
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The NHS Long Term Plan sets out the steps to improve the diagnosis of all cancers, including kidney cancer. This includes the establishment of Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise. The Centres build on the 10 models being piloted through the Accelerate, Coordinate and Evaluate programme, which have focussed on diagnosing cancers where patients often present with non-specific symptoms and may go to their general practitioner (GP) many times before being sent for tests.</p><p> </p><p>The NHS Long Term Plan also reaffirms that all GPs should use the latest evidence-based guidance from the National Institute for Health and Care Excellence (NICE) to identify adults at risk of cancer. The NICE NG12 referral guidelines for suspected cancer recommend that GPs refer those aged over 45 with visible hematuria who do not have a urinary tract infection for investigative tests and are available at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers" target="_blank">https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers</a></p><p> </p><p>Over the last two financial years, over £200 million funding has been provided through our Cancer Alliances to transform earlier diagnosis and personalised care.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213990 question first answered 06/02/2019 15:09:56 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050633

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government plans to take in the next five years to reduce the number of patients with kidney cancer who are misdiagnosed; and if he will make a statement.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213990
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The NHS Long Term Plan sets out the steps to improve the diagnosis of all cancers, including kidney cancer. This includes the establishment of Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise. The Centres build on the 10 models being piloted through the Accelerate, Coordinate and Evaluate programme, which have focussed on diagnosing cancers where patients often present with non-specific symptoms and may go to their general practitioner (GP) many times before being sent for tests.</p><p> </p><p>The NHS Long Term Plan also reaffirms that all GPs should use the latest evidence-based guidance from the National Institute for Health and Care Excellence (NICE) to identify adults at risk of cancer. The NICE NG12 referral guidelines for suspected cancer recommend that GPs refer those aged over 45 with visible hematuria who do not have a urinary tract infection for investigative tests and are available at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers" target="_blank">https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers</a></p><p> </p><p>Over the last two financial years, over £200 million funding has been provided through our Cancer Alliances to transform earlier diagnosis and personalised care.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213989 question first answered 06/02/2019 15:09:56 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050634

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government has made an assessment of the potential merits of allocating funding to research into the development of a national screening programme for kidney cancer; and if he will make a statement.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213991
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four nations about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.</p><p> </p><p>The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer. Therefore an assessment of the potential merits of allocating funding for research has not been made.</p><p> </p><p>Nevertheless, Public Health England has funded a Be Clear on Cancer ‘Blood in pee’ campaign which ran across England from July to September 2018, which aimed to raise awareness and improve early diagnosis of bladder and kidney cancer.</p><p> </p><p>The NHS Long Term Plan, published on 7 January, sets out a comprehensive package of measures that will transform cancer diagnosis and treatment across the country over the next 10 years; a decade in which patients can expect to see huge improvements in the prevention, diagnosis and treatment of cancer. The aim is to see 55,000 more people surviving cancer for five years in England each year from 2028.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/02/2019 15:23:44 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050635

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what recent steps he has taken to implement the target of diagnosing 75 per cent of cancers at stage one or stage two by 2028; and if he will make a statement.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213992
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition – to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.</p><p> </p><p>The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213993 question first answered 06/02/2019 15:17:34 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050636

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the evidential basis was for his Department's target of diagnosing 75 per cent of cancers at stage one or stage two by 2028 and if he made an assessment of the feasibility of setting that target at 2025.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213993
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition – to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.</p><p> </p><p>The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213992 question first answered 06/02/2019 15:17:35 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050637

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether cryoablation needles will remain available through the High Cost Tariff Excluded Device List with no changes to current funding arrangements in each of the next five years.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213994
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The consultation for the 2019/20 national tariff is currently live and information can be found at the following link:</p><p> </p><p><a href="https://improvement.nhs.uk/resources/national-tariff-1920-consultation/" target="_blank">https://improvement.nhs.uk/resources/national-tariff-1920-consultation/</a></p><p> </p><p>It is proposed that radiofrequency, cryotherapy and microwave ablation probes and catheters should remain on the list.</p><p> </p><p>The current proposals are for a one year tariff and no decisions have been made on the composition of the high cost excluded device list for future years.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 06/02/2019 17:28:28 answering member 1585 label Biography information for Stephen Hammond
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1050044

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco: Sales
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2018, whether products produced before the UK leaves the EU will still be legal to sell after the UK leaves the EU.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	213284
answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>In the event of the United Kingdom leaving the European Union without a deal, the Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 allow for tobacco products produced before exit day, with EU picture warnings, to be sold for 12 months after exit day. Any products manufactured after exit day will need to include the new picture health warnings which are introduced by the above legislation.</p><p> </p><p>Tobacco products and e-cigarettes which have been notified via the EU notification system prior to exit day will not need to be notified again after exit day, unless there are substantive change to products.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:00:31 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1045483

registered interest
date	21/01/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Employment: Parents
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has consulted (a) parents, (b) employers and (c) other organisations as part of its internal review of workplace provision for parents of premature babies.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	210495
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>The Department is conducting a short, focussed internal review of the provisions for parents of premature and sick babies and those that experience multiple births. The purpose of this work is to obtain a high-level understanding of the barriers to participating in the labour market that these parents can face.</p><p>BEIS officials are working with organisations who represent the interests of these parents (The Smallest Things, Bliss, and TAMBA) to better understand the issues that parents can face and have also held focus groups with a small number of parents themselves.</p><p>We are also considering options for addressing other information gaps – including those that are attributable to regional variations in provision and experiences of parents.</p><p> </p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst grouped question UIN 210496 210497 question first answered 28/01/2019 15:38:08 answering member 4487 label Biography information for Kelly Tolhurst
tabling member	1521 label Biography information for Mrs Sharon Hodgson